Elliott Management said it bought 8.1 percent stake in Mentor Graphics, calling on the company to pursue "strategic opportunities."
Rishi Khosla, CEO of OakNorth Bank, explains why Brexit has benefited smaller banks.
CBOE is buying BATS for $32.50 per share, reports CNBC's Andrew Ross Sorkin
Two sources said Twitter was looking for at least $30 billion to sell, Recode reports.
In total, 30 brands will fall under the Marriott umbrella to create the world's largest hotel chain with more than 1.1 million rooms.
CNBC's Geoff Cutmore speaks to Phosagro CEO Andrey Guryev, who views the recent Bayer/Monstanto deal as a positive for the agrochemical industry.
Informa is resilient to Brexit risks as its market in continental Europe is small, and the company remains focused on global growth, says CEO Stephen Carter.
Stephen Carter, CEO at Informa, explains his proposed acquisition of Penton, the U.S. exhibitions and professional information service group, for £1.18 billion.
Dr Brian McGee, engagement manager at Novasecta, discusses Bayer's expected acquisition of agrochemical firm Monsanto.
Peter Oppenheimer, chief global equities strategist at Goldman Sachs, explains why there are a lot of reasons to expect more mergers and acquisitions.
EOG Resources said it would buy Yates Petroleum for $2.5 billion, the latest move by a U.S. energy firm to acquire acreage in the Permian Basin.
John Rountree, managing partner at Novasecta, discusses the viability of Bayer's latest attempt to buy Monsanto.
In light of the M&A news surrounding Monsanto and Bayer, Mark Phelps, CIO of concentrated global equities at Alliance Bernstein, explains why more mergers are on the horizon.
Simon Weeden, head of European telecoms research at Citi, discusses the profitability of French conglomerate Bouygues and the wider French telecoms market.
Neil Campling, senior vice-president and head of global TMT research at Northern Trust Securities, explains the value of British technology firm ARM, ahead of its potential acquisition by Japan's SoftBank.
One Kings Lane fetched less than $30 million in its recent sale to Bed Bath & Beyond, Recode reports.
Alex Tarrant, assistant editor at Dealreporter Europe, Mergermarket Group, shares his views on the deal between Pfizer and Medivation.
Liverpool Football Club's owners haven't received a bid, a club source said on Sunday, after reports of interest from a Chinese-led consortium.
Hedge fund ValueAct took a fresh Morgan Stanley stake, but the activist investors weren't necessarily angling for major changes at the bank.
Hilary Wilson, business development manager of investment banking strategy division at Dealogic, discusses M&A activity since the Brexit vote.